European Journal of Clinical Investigation

Eur J Clin Invest

0014-2972

1365-2362

Therapeutic Area

Biology, Cytology/Cell Biology, Endocrinology/Metabolism, Genomics, Immunology, Molecular Medicine, Pathology, Physiology, Research

Biologists, Biomedical Researchers, Cell Biologists, Clinicians, Cytologists, General Practitioners, Immunologists, Internists, Molecular Biologists, Pathologists, Physicians, Physiologists, Researchers, Scientists

EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.

European Society for Clinical Investigation (ESCI)

Wiley-Blackwell

Impact Factor JCR Categories/Rank Circulation Submission to Acceptance Acceptance to Online Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines